Iovance Biotherapeutics (IOVA) Misses Q3 EPS by 1c
Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).“We continue making great ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)